Archive for June, 2016

CDC Notification – Liquid Docusate

The Centers for Disease control (CDC) has communicated a warning regarding the use of liquid docusate in certain patients due to the risk of Burkholderia cepacia infections.  The identified infections have occurred primarily in ventilated patients without cystic fibrosis who are being treated in intensive care units. The CDC recommends that facilities not use any liquid docusate for patients who are critically ill, ventilated or immunosuppressed. Please contact Kimberly Griego, PharmD at KGriego@contractpharmacy.com or 267-487-9033 with any questions.
Continue Reading

Significant Shortages – Bicillin L-A & Tylenol ER 650mg

Bicillin L-A Shortage Update CPS currently does not have Bicillin L-A (penicillin G Benzathine) injection in stock.  All products are currently on backorder due to manufacturing delays.   CPS is in close contact with wholesalers regarding this shortage and it is anticipated the manufacturer will be shipping product soon. Bicillin L-A is penicillinase-sensitive penicillin indicated for mild to moderate upper respiratory Streptococcus infections and syphilis.  Bicillin L-A is the recommended treatment for syphilis and is the only option for pregnant women infected with[...]
Continue Reading

Bicillin L-A Shortage

There is a significant shortage of Bicillin L-A (penicillin G Benzathine) injection.  All products are currently on backorder due to manufacturing delays. Bicillin L-A is penicillinase-sensitive penicillin indicated for mild to moderate upper respiratory Streptococcus infections and syphilis.  Bicillin L-A is the recommended treatment for syphilis and is the only option for pregnant women infected with or exposed to syphilis. The Centers for Disease Control and Prevention (CDC) recommends that until the shortage of Bicillin L-A is resolved, clinicians should consider prioritizing[...]
Continue Reading

Affordable Care Act – Payroll Business Journal (PBJ) Reporting of Consultant Pharmacy Time

Beginning July 2016, skilled nursing facilities will be required to electronically submit staffing and census data to CMS.  To assist our clients with the submission of consultant pharmacist data, Contract Pharmacy Services will be adding an additional document to your monthly invoices.  This process will begin with your June 2016 invoice and will include the following data in a spreadsheet format with a separate line item for each date of consulting for both your skilled and your PC/AL consulting: Job title[...]
Continue Reading

DRUG SHORTAGE– IV Antibiotics and Add-vantage Normal Saline

Contract Pharmacy Services is advising customers that we continue to experience significant shortages of a number of IV antibiotic products.  At this time these products are unavailable or are in limited supply. To ensure timely availability of treatment to your residents select an alternative product when initially ordering IV antibiotics.  Below are some alternatives to consider. Normal Saline Add-vantage is in short supply. Due to this all Add-vantage IV medications can only be supplied in D5W. Pipercillin/Tazobactam (Zosyn) 375 gm and 4.5 gm[...]
Continue Reading

June Medications in the News

Drug’s Name Changes Due to Safety Concerns The US Food and Drug Administration (FDA) has approved a brand name change for the antidepressant Brintellix (vortioxetine, Takeda) to decrease the risk of prescribing and dispensing errors due to name confusion with the antiplatelet Brilinta (ticagrelor, AstraZeneca). The new brand name for vortioxetine will be Trintellix, and it is expected to be available starting in June 2016. Which Fluoroquinolone Antibiotic Carries the Greatest Risk of Tendinopathy? Tendinitis and tendon rupture are known serious adverse effects tied[...]
Continue Reading
Footer Logo

CONTACT US